Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.

Article

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 166. 166-. ISSN 1478-6354

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 115. ISSN 1478-6354

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

Dougados, M, Van der Heijde, D, Chen, YC et al. (11 more authors) (2017) Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: Results from the RA-BUILD study. Annals of the Rheumatic Diseases, 76 (1). pp. 88-95. ISSN 0003-4967

This list was generated on Mon Aug 3 00:56:14 2020 BST.